Graf Akcie ACAD (Acadia Pharmaceuticals Inc). Diskuze k akciím ACAD. Aktuální informace ACAD.

Základní informace o společnosti Acadia Pharmaceuticals Inc (Akcie ACAD)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 2.8B
Hodnota podniku (EV) 2.18B
Tržby 463.359M
EBITDA -259.53
Zisk -261.74
Růst v tržbách Q/Q 4.65 %
Růst v tržbách Y/Y 17.88 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.52
EV/Sales 4.70
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 6.04
P/FCF N/A
Price/Book 4.47
Účetní hodnota na akcii 3.99
Hotovost na akcii 4.06
FCF vůči ceně -5.02 %
Počet zaměstnanců 601
Tržba na zaměstnance 770.980k
Profit margin -63.74 %
Operating margin -56.88 %
Gross margin 97.69 %
EBIT margin -56.33 %
EBITDA margin -56.01 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst 0.00 %
EPS - Očekávaný růst příští rok -51.85 %
Return on assets -34.24 %
Return on equity -43.11 %
ROIC -35.89 %
ROCE -41.49 %
Dluhy/Equity 0.25
Čistý dluh/EBITDA 8.57
Current ratio 6.77
Quick Ratio 6.66
Volatilita 3.94
Beta 0.28
RSI 57.33
Cílová cena analytiků 60
Známka akcie (dle analytiků) 1.11
Insider ownership 0.40 %
Institutional ownership 93.08 %
Počet akcií 160.643M
Procento shortovaných akcií 6.05 %
Short ratio 3.84 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie ACAD

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$339.076$223.807$124.901$17.331$0.061$0.12
Cost Of Goods Sold$11.344$12.377$9.077$3.075--
Gross Profit$327.732$211.43$115.824$14.256$0.061$0.12
Research And Development Expenses$240.385$187.163$149.189$99.284$73.869$60.602
SG&A Expenses$325.638$265.758$255.062$186.456$88.304$32.748
Other Operating Income Or Expenses$-8.254$-5.953$-3.983$-1.331$-2.5-
Operating Expenses$585.621$471.251$417.311$290.146$164.673$93.35
Operating Income$-246.545$-247.444$-292.41$-272.815$-164.612$-93.23
Total Non-Operating Income/Expense$12.162$3.508$4.126$2.763$0.499$0.755
Pre-Tax Income$-234.383$-243.936$-288.284$-270.052$-164.113$-92.475
Income Taxes$0.876$1.256$1.119$1.341$0.33-
Income After Taxes$-235.259$-245.192$-289.403$-271.393$-164.443$-92.475
Other Income------
Income From Continuous Operations$-235.259$-245.192$-289.403$-271.393$-164.443$-92.475
Income From Discontinued Operations------
Net Income$-235.259$-245.192$-289.403$-271.393$-164.443$-92.475
EBITDA$-247.392$-245.017$-289.988$-270.898$-166.025$-92.54
EBIT$-246.545$-247.444$-292.41$-272.815$-164.612$-93.23
Basic Shares Outstanding14712712311610197
Shares Outstanding14712712311610197
Basic EPS$-1.60$-1.94$-2.36$-2.34$-1.63$-0.95
EPS - Earnings Per Share$-1.60$-1.94$-2.36$-2.34$-1.63$-0.95
# 2020 2019 2018 2017 2016 2015
Current Ratio10.16028.83257.617312.8669.998620.5013
Long-term Debt / Capital---0.0003--
Debt/Equity Ratio---0.0003--
Gross Margin96.654494.469892.732782.2572100100
Operating Margin-72.7109-110.5613-234.1134-1574.145-269855.8-77691.67
EBIT Margin-72.7109-110.5613-234.1134-1574.145-269855.8-77691.67
EBITDA Margin-72.9607-109.4769-232.1743-1563.084-272172.1-77116.67
Pre-Tax Profit Margin-69.124-108.9939-230.81-1558.202-269037.7-77062.5
Net Profit Margin-69.3824-109.5551-231.7059-1565.94-269578.7-77062.5
Asset Turnover0.43290.41430.32480.03090.00030.0004
Inventory Turnover Ratio1.7893.0411.72960.7365--
Receiveable Turnover8.95278.05386.7772.42730.03720.1245
Days Sales In Receivables40.769745.320253.8583150.37229801.1472932.167
ROE - Return On Equity-33.65-51.1799-86.3155-52.3509-82.3195-29.8799
Return On Tangible Equity-33.7749-51.6175-87.7652-53.0691-82.3195-29.8799
ROA - Return On Assets-30.0388-45.389-75.2662-48.3635-74.1082-28.4138
ROI - Return On Investment-33.65-51.1799-86.3155-52.3351-82.3195-29.8799
Book Value Per Share4.50263.33032.6954.27141.95963.0934
Operating Cash Flow Per Share0.29630.45320.0226-0.5885-0.5272-0.3125
Free Cash Flow Per Share0.30520.44320.029-0.5802-0.5466-0.3073